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Impaired light detection of the circadian clock
in a zebraﬁsh melanoma model
Noemie Hamilton*, Natalia Diaz-de-Cerio, and David Whitmore*
Center for Cell and Molecular Dynamics; Department of Cell and Development Biology; University College London; London, UK
Keywords: cancer, cell cycle, circadian clock, light input, melanoma, zebrafish
The circadian clock controls the timing of the cell cycle in healthy tissues and clock disruption is known to increase
tumourigenesis. Melanoma is one of the most rapidly increasing forms of cancer and the precise molecular circadian
changes that occur in a melanoma tumor are unknown. Using a melanoma zebraﬁsh model, we have explored the
molecular changes that occur to the circadian clock within tumors. We have found disruptions in melanoma clock gene
expression due to a major impairment to the light input pathway, with a parallel loss of light-dependent activation of
DNA repair genes. Furthermore, the timing of mitosis in tumors is perturbed, as well as the regulation of certain key cell
cycle regulators, such that cells divide arhythmically. The inability to co-ordinate DNA damage repair and cell division is
likely to promote further tumourigenesis and accelerate melanoma development.
Introduction
Most organisms possess a highly conserved endogenous circa-
dian clock, providing a clear survival advantage to animals that
live under an environmental light and dark cycle.1 The molecular
clock mechanism operates through a transcription-translation
negative feedback loop of circadian genes and proteins. The alter-
nating activation and suppression of core clock genes, such as
Clock, Bmal, Per and Cry, produce a 24 h oscillation, which can
then regulate the timing of a wide range of downstream, output
processes.2,3 One of the most significant of these outputs is the
daily control of cell proliferation and DNA repair, which has
been shown in numerous tissues across many animal model sys-
tems.4-7 We have previously reported that this cellular clock con-
trols cell cycle events in normal proliferative tissues from early
development until adulthood in zebrafish. This cellular clock also
controls the timing of the cell cycle in cell culture, with S-phase
occurring in the late day/early evening and mitosis in late night/
early morning.6,7 The clock regulation of key cell cycle regula-
tors, such as the inhibitors p21 and p20, creates a window or gate
that permits cells to enter S-phase from G1 when expression lev-
els are low.8
Circadian clock disruption is associated with numerous health
problems and has been linked to an increased incidence of can-
cer.9 Epidemiologic studies, for example, have revealed an
increased risk of breast and colorectal cancers in night shift work-
ers.10-12 The hypothesis of a disrupted clock involved in cancer
development has also been supported by studies in rodents.
Mice, whose clock had been surgically disrupted by removal of
the suprachiasmatic nucleus, and then inoculated with tumor
cells showed an increase in tumourigenesis.13 Environmental
clock disruptions by constant light or jet lag exposure in rats and
mice have also revealed an increase in spontaneous tumor appear-
ance and tumor growth.13-15 Several clock genes have been pro-
posed to act as tumor suppressors and the PER family of proteins
in particular appears to play a role in DNA damage repair and
tumor suppression. Over expression of Per1 in colon cancer cell
lines was associated with a higher level of apoptosis after irradia-
tion, whereas inhibition of Per1 expression led to a decrease in
apoptosis.16 Similar effects were observed with Per2 in a leukemia
cell line.17 Transgenic mice lacking both Per1 and Per2 showed
higher rates of tumourigenesis after irradiation.18 Moreover can-
cer patients commonly show disruptions in their circadian clock,
which is nowadays being used as a prognostic tool for breast can-
cer patients.19 Chronochemotherapy has emerged as a treatment
strategy, with the discovery of a circadian profile for drug target
genes, including those involved in the cell cycle. This mode of
treatment takes advantage of the asynchrony between healthy
and cancerous tissues and has proven to be successful in deliver-
ing treatment at an optimal time of day to increase survival of
colorectal cancer and childhood acute leukemia patients com-
pared to normal, non-timed protocols.20-22
Melanoma is a very severe and significant form of skin cancer,
with approximately 20% of diagnosed individuals succumbing to
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the disease. It is also a form of cancer that is showing the most
dramatic increase in incidence within the population. This num-
ber is set to rise even further in Western countries, as travel to
sunny locations and exposure to DNA-damaging UV light has
escalated in recent years.23,24 Human skin is very sensitive to
light exposure, especially in the UV range, which can lead to
DNA damage and the initiation of melanoma.25,26 Skin cells
have been shown to contain a robust biological clock in mam-
mals although the function of this skin clock is generally
unknown.27-30 There is evidence for a role of the circadian clock
in maintaining stem cell heterogeneity in the epidermis and the
timing of DNA replication appears to be under clock-control in
keratinocytes.31,32 Analysis of clock gene expression in human
skin and melanoma tumor biopsies showed down regulation in
tumor samples.33 However, the circadian profile of clock genes
and clock-controlled genes (CCGs) remains unexplored in mela-
noma. How clock-cell cycle interactions function in a melanoma
tumor environment is an important issue and one of considerable
clinical significance.
Zebrafish have already proven to be an excellent vertebrate
system in which to study melanoma, due in part to the high gene
homology to mammals in cancer related pathways.34,35 Using a
zebrafish melanoma model, we have analyzed the circadian pro-
file of clock gene expression over several days in vivo and in vitro
and observed a down regulation of clock gene expression in mela-
noma tumors compared to healthy skin. We have shown that
impaired light detection in melanoma tumors may underpin the
disruptions observed in central circadian clock components. It is
also clear that the circadian timing of mitosis itself is disrupted in
these tumors, along with corresponding changes in gene expres-
sion. Loss of light detection also compromises induction of the
DNA-damage repair pathways, a fact that may promote further
cellular mutations, and promote additional, accelerated tumor
growth.
Results and Discussion
Clock gene expression is altered in zebrafish melanoma
tumors
To explore the expression profile of clock genes in melanoma
we used transgenic zebrafish Tg(mitfa:V12Ras) expressing the
constitutively active V12Ras under the control of the melanocyte
specific promoter mitfa.35,36 These animals were crossed to nacre
(mitfa¡/¡) animals to generate a Tg(mitfa:V12Ras);mitfa¡/¡
strain lacking melanocytes. Injection of a miniCoopR-GFP vec-
tor [33] into zygotes from a Tg(mitfa:V12Ras);mitfa¡/¡ £
mitfa¡/¡ cross was then used to rescue the melanocyte lineage in
offspring and induce more penetrant and rapid melanoma devel-
opment than observed in Tg(mitfa:V12Ras) alone. In parallel, the
miniCoopR-GFP vector drives expression of GFP in rescued
melanocytes.36 All Tg(mitfa:V12Ras);mitfa¡/¡;miniCoopR-
GFPC (henceforward V12RasC; GFPC) animals developed dys-
plastic melanocytic pigmentation pattern from day 4, and conse-
quently GFP-labeled melanoma tumors at around 4 weeks of age
while their mitfa¡/¡; miniCoopR-GFPC (henceforward GFPC)
siblings showed normal pigmentation and no tumor (Fig. S1).
Expression of key clock genes was explored in-vivo in mela-
noma tumors from V12RasC; GFPC zebrafish and compared to
expression in healthy skin harvested from control GFPC animals.
qPCR analysis showed a significant down-regulation of clock
gene expression in tumors compared to healthy skin samples
(Fig. 1A). Samples were collected every 6 hours over 4 days,
2 days under light-dark (LD) conditions, and 2 subsequent days
in constant dark (DD), free-running conditions. In LD, we
observed shallow rhythms, with significantly reduced amplitude,
for the core clock genes per1, clock and bmal1a in tumor com-
pared to robust rhythms in healthy skin (Fig. 1A, Tables S1, S2).
The significant reduction in amplitude under LD conditions is
quantified in Figure 1B.
A reduction in circadian clock amplitude has been reported in
other types of cancer such as breast, prostate, non-small cell lung
cancer, and head and neck squamous cell carcinoma.37-40 In par-
ticular, a study on human melanoma tumor biopsies has reported
a significant down regulation of clock genes compared to adja-
cent healthy tissues.33 However, human skin contains different
cell types displaying a range of amplitudes in clock gene rhythms,
with keratinocyte and dermal fibroblast cultures showing a more
robust clock compared to melanocyte cultures.28 To ensure that
the difference in amplitude we observed between normal skin
and melanoma tumors in our study is not due to a higher num-
ber of melanocytes in tumor samples, we analyzed clock gene
expression in zebrafish dysplastic naevi (Fig. S2). Dysplastic naevi
appear during the radial growth phase of melanoma development
and lack alterations in certain pathways, such as phosphoinositide
3-kinase (PI3K)-AKT signaling, required for the vertical growth
phase and formation of a melanoma tumor.35 Naevi, therefore,
provide a melanocyte-rich environment, which has not yet pro-
gressed to a malignant melanoma (Fig. S1). Analysis of per1,
clock1 and bmal1a expression across one LD cycle showed no
down regulation in naevus samples compared to healthy skin
(Fig. S2). This result indicates that the decreased amplitude in
clock gene expression seen in melanoma tumors is most likely
due to malignant transformation itself and not to the abundance
of melanocytes.
Interestingly, under DD conditions, we found very little dis-
ruption of clock gene expression in tumors when measured by
qPCR (Fig. 1A). However, cosinor analysis of the data revealed a
significant increase of the mesor in tumors versus skin but most
importantly the amplitude relative to the mesor showed a signifi-
cant decrease for per1, bmal1a and clock (Tables S1, S2), suggest-
ing a defective molecular clock in the tumor population.
However, the tumor situation in vivo is quite complex in that
healthy tissues are surrounding a heterogeneous tumor. To deter-
mine the impact of malignancy on clock function in the tumor
more precisely it is essential to follow circadian oscillations within
single tumors dynamically and in vitro. We consequently exam-
ined clock rhythms in tissue culture of single tumors and healthy
skin controls expressing period3-luciferase in bioluminescent
assays across 4 days in LD then transferred to DD (Fig. 1C).
Under these conditions, the period length of the circadian
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oscillator showed no statistical difference between tumor and
skin, either in LD or DD (Fig. 1D). However in LD, the ampli-
tude was dramatically reduced in tumors compared to skin
(Fig. 1E), even more so than in our in vivo qPCR analysis
(Fig. 1A, B). Moreover, the amplitude of tumor circadian
rhythms dampens rapidly when transferred to DD compared to
data shown in vivo by qPCR in Figure 1A (Fig. 1E). The
circadian pacemaker in tumors in vitro, therefore, appears more
disrupted than in vivo, possibly due to the lack of support from
surrounding healthy tissue. This suggests that healthy surround-
ing tissues are likely to play a role in maintaining tumor rhyth-
micity in vivo, though the mechanism of oscillator coupling is far
from clear. Nevertheless, we have shown that the circadian clock
does continue to function within the melanoma, if with reduced
Figure 1. Clock gene expression is downregulated in zebraﬁsh melanoma tumors. (A) qPCR analysis of core clock genes per1, clock1, and bmal1a in
tumors and skin from animals maintained on a LD cycle, then transferred to DD. Relative expression to the reference gene represents the mean § SEM
of a minimum of 5 samples per time point. White and gray backgrounds represent light and dark phases respectively. (B) Quantiﬁcation of the reduction
in amplitude in tumors using skin as a reference. Data represent the mean § SEM of 5 samples. (C) Bioluminescent traces of per3-luciferase tumors and
skin in LD, then transferred to DD. Results are presented as detrended data from representative samples and white and black bars under the traces repre-
sent light and dark phases respectively. (D) Period lengths in LD and DD, calculated from the bioluminescent data, are presented in hours. (E) Amplitude
differences between skin and tumors in LD and DD from the bioluminescent data are presented in counts per second (CPS). Data represent the mean §
SEM of 12 samples using a Student’s t-test (unpaired, 2-tailed; ***P < 0.001).
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amplitude. This reduction in robustness could be due to a variety
of alterations in tumor clock function, including perturbation of
the light input pathway, reduced cellular coupling between oscil-
lators or disruption in the regulation of the core clock mechanism
within each cell.
Impaired light detection in the tumor reduces induction of
genes involved in clock entrainment and the DNA-damage
repair system
Light is the main entraining signal to the circadian clock, and
the majority of zebrafish cells and tissues are themselves directly
Figure 2. Impaired light detection and DNA-damage repair system. (A) qPCR analysis of light inducible clock genes per2 and cry1a and light dependent
DNA-damage repair genes 6,4ph (6,4 photolyase) and ddb2 (DNA damage binding protein 2). Relative expression to the reference gene represents the
mean § SEM of minimum 5 samples per time point. (B) qPCR analysis cry1a, per2, ddb2 and 6,4ph expression in skin and tumor after a 3 hour light pulse
given at CT16 compared to samples kept in the dark (DD). Data represent the mean § SEM of a minimum of 5 samples per time point. (C) Absolute fold
induction of each gene in response to light in skin and tumor. Fold induction was compared between skin and tumor using a Student’s t-test (unpaired,
2 tailed; **P< 0.01; ***P < 0.001). Data represent the mean § SEM of 8 samples.
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light responsive.41 Two light-inducible clock genes, cry1a and
per2, have been shown to play a critical role on the light input
pathway to the clock in zebrafish.42,43 We examined by qPCR
the expression of these 2 genes in vivo in LD and then transferred
into DD. Cry1a expression was dramatically down regulated in
tumor samples in LD, but showed similar levels in DD compared
to skin samples (Fig. 2A). Cry1a expression is under clock control
as well as being light inducible, a fact that explains the similar
oscillation that continues in constant darkness. The light-induc-
ible clock gene most disrupted in the tumor was per2 with more
than an 80% reduction in amplitude in tumor samples compared
to skin (Fig. 2A, Fig. S3). The dramatic reduction in expression
of the 2 genes known to be involved in zebrafish clock entrain-
ment is likely to contribute to the reduced amplitude rhythms in
LD shown in Figure 1. In many respects, it is an unexpected
result that the light input pathway to the clock is so strongly
affected in this zebrafish model of melanoma, even when one
takes into account the fact that the skin is very strongly light
responsive. In mammals there is no evidence at this time that
peripheral tissues are themselves directly light sensitive. A
detailed analysis of clock function in a mammalian melanoma
context is certainly important. However, many of the genes
involved in the clock system are highly conserved between zebra-
fish and mammals, even if there are changes in their specific roles.
This is certainly true in the case of both period 2 and cryptochrome
genes. There is also considerable evidence that per2 can act as a
tumor suppressor in mammalian systems.44,45 Disruption of per2
expression, either when it is acting as a component of the circa-
dian clock mechanism as in mammals, or the light input pathway
as in zebrafish, could potentially play a significant role in
enhanced tumourigenesis.
Melanoma tumors often appear black due to the melanin pig-
ment present in melanocytes. To ensure that this extra pigmenta-
tion of the tissue does not affect the ability of the tumor to
perceive light, we analyzed the expression of per2 and cry1a in
naevi, which are also highly pigmented. Per2 and cry1a showed no
down regulation of expression in naevi but interestingly a slightly
greater amplitude compared to skin samples (Fig. S4). We can
therefore conclude that there is a defect in the pathway leading to
the induction of light responsive genes in melanoma tumors, not
resulting from the increased pigmentation, and which may lead to
a reduction in the robustness of the clock rhythm measured in
these tumors relative to neighboring, healthy tissue.
Transcriptional regulation by light can also directly affect other
cellular processes, such as DNA damage repair pathways.46,47
Expression of the DNA-damage repair genes ddb2 and 6,4 photo-
lyase (6,4ph) displays a robust oscillation in LD peaking 3 h after
lights on (Zeitgeber Time—ZT3) in skin samples, which is then
lost when tissues are transferred to DD (Fig. 2A). However, the
expression profile of these genes in tumor samples lacks such oscil-
lations in LD, showing arrhythmic expression and a reduction of
more than 80% in expression levels compared to skin samples
(Fig. 2A, Fig. S3). A cosinor analysis of these data confirms that
there are no significant rhythms in tumor samples (Tables S3,
S4), and shows that the loss of light sensitivity impacts not only
clock gene expression, but also DNA repair gene induction even
more dramatically. Analysis of ddb2 and 6,4ph gene expression
across a LD cycle in naevi compared to tumor and skin samples
showed a gradient of down regulation (Fig. S5). This is in agree-
ment with studies on dysplastic melanocytes displaying an
impaired DNA damage repair system, creating an environment
prone to increased genome instability and allowing for the naevi
to progress to melanoma.48 This partial loss of light induction in
DNA damage repair genes in naevi, at an early stage of melanoma
development, establishes a situation that promotes and possibly
even accelerates subsequent tumor growth.
To assess the light input pathway in melanoma tumors, we
examined the induction of cry1a, per2, and 4 DNA damage
repair genes following a 3 h light pulse during the subjective
night (Fig. 2B). The expression of all genes was greatly enhanced
following the light pulse in control skin samples, as previously
reported in zebrafish cell lines and larvae.42,47 The acute light
response was significantly reduced for cry1a expression in tumors,
and no significant response occurred at all for per2 and DNA-
damage repair genes (Fig. 2B). All light-inducible genes exam-
ined showed a significant absolute fold reduction in expression,
which demonstrates the profound impairment in the light detec-
tion pathway in melanoma tumors (Fig. 2C). A functional DNA
repair system is essential to protect against mutations caused by
UVA and UVB light, especially in skin cells. ddb2 and 6,4ph
expression in healthy skin was shown to peak at the start of the
day therefore providing optimal protection against UV-induced
mutations. Melanoma tumors, however, lack light inducible
expression of these key DNA damage repair genes, which suggest
that their DNA-repair mechanisms will be compromised, and
consequently, they are prone to attaining even greater levels of
DNA damage and genomic instability.
Melanoma tumors display disruption in the timing of clock
output events
Controlled timing of the cell cycle is one of the major circa-
dian clock outputs. We have previously reported that key cell
cycle regulators are clock controlled in zebrafish cell lines and
embryos.6,8,49 To explore the circadian expression profiles of cell
cycle genes in healthy skin and melanoma tumors, we collected
tissue samples at 6-hour intervals over LD and DD cycles for
4 days. qPCR analysis of mitotic-related genes (cyclin B1, cdk1,
wee1) in skin showed rhythmic expression in LD, with peak
expression during the early night (Fig. 3A). In comparison,
expression in tumor showed clear disruption, including loss of
rhythmicity in wee1 in LD, and amplitude variations in cyclinB1
and cdk1. All mitotic genes showed a loss of rhythmicity in DD
(Fig. 3A, Tables S5, S6), suggesting that the circadian clock
might have reduced control over the timing of mitosis. To deter-
mine if this disruption in mitosis-related gene expression affected
actual mitotic timing, we used a phospho-histone H3 (pH3)
antibody to label cells in mitosis in zebrafish skin and tumor sec-
tions at 4 different time points across a LD cycle. Skin samples
showed a rhythm in mitosis with the highest percentage of pH3
positive cells found during the late night (ZT21) (Fig. 3B).
Tumor samples did not show any rhythm in mitotic events with
a high degree of variability in the percentage of pH3 positive cells
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at each time point. Interestingly, the average index of mitotic
events remained similar throughout the skin and tumor samples,
suggesting that the overall number of cells undergoing mitosis is
very similar (Fig. S6). Most healthy skin cells undergo mitosis at
night, possibly to avoid any negative consequences caused by UV
light exposure during the day, whereas tumor cells divide ran-
domly at any time of day.
We have hypothesized that the timing of S-phase entry is reg-
ulated by 2 CCGs, p20 and p21, which control tissue specific S-
phase timing in zebrafish.8 To identify which of these inhibitors
is the most abundant in skin we compared their expression across
a LD cycle in skin samples and found that p20 is significantly
more abundant than p21 in this particular tissue (Fig. 4A). The
circadian profile of p20 expression showed robust rhythms in
skin samples, peaking in the night at ZT15 (Fig. 4B). We have
previously reported similar findings in zebrafish embryos, where
p20 is the main regulator in the developing brain. In the develop-
ing zebrafish larvae p20 shows a clear phase difference in expres-
sion compared to p21, where it is responsible for timing actual S-
phase events to ZT3, in the early day.8 This peak at ZT3 in S-
phase would be highly appropriate in skin, as it would coincide
with the peak in expression of DNA repair genes, therefore possi-
bly providing protection against UV light-induced mutations
during the process of DNA replication. Surprisingly, tumor sam-
ples revealed a similar p20 expression pattern in LD, suggesting
that the regulation of S-phase timing is not disrupted in tumors
unlike the regulation of mitosis. However, rhythms in p20 in
DD do become less precise over time in tumors, which may be a
reflection of the somewhat disrupted circadian pacemaker in
these cells. Other S-phase genes such as p21, cdk2 and PCNA
showed an up-regulation in expression in tumor samples in LD
and DD, with a loss of rhythmicity in DD for cdk2 and PCNA
compared to skin samples (Fig. 4B, Tables S5, S6). We can con-
clude that the cell cycle in melanoma tumors displays disrupted
circadian properties with a loss in rhythmicity of several genes,
especially those involved in mitosis.
We have demonstrated in this study that light-inducible
genes, such as cry1a and per2, showed a reduced response to light
in zebrafish melanoma compared to healthy skin. This impaired
light response also resulted in a total loss in expression of light-
induced DNA damage repair genes during the daytime, when
UV-induced mutation risk is at its highest. We believe that this
impaired light response, observed in tumors, could reduce the
strength of entrainment of the clock and may lead to the reduced
amplitude in clock gene oscillations in LD. The lower level of
expression of clock genes in tumors is also likely to reduce the
level of precise control over cellular clock outputs, such as the cell
cycle. Key cell cycle genes show a loss of circadian regulation,
and mitotic events consequently are also no longer rhythmic,
Figure 3. Disruption in mitotic events in melanoma tumors. (A) qPCR analysis of mitotic genes cyclin B1, cdk1 and wee1 in healthy skin and tumors. Rela-
tive expression to the reference gene represents the mean § SEM of minimum 5 samples per time point. (B) Quantiﬁcation of mitotic events in healthy
skin and tumors using an antibody to phospho-Histone H3 (pH3). Data represent the percentage of pH3-positive cells relative to the total number of cells
in one section. Data represent the mean § SEM of a minimum of 3 different ﬁsh. The percentage of pH3 positive cells were compared at each time point
for skin and tumor using a one-way ANOVA test followed by a Newman-Keuls multiple comparison post test (*P < 0.05, ns D non signiﬁcant).
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meaning that cell division occurs to a greater extent during the
day compared to healthy skin. The coupling process between the
circadian clock and control of mitosis is clearly disrupted in mel-
anoma. Loosing the ability to repair DNA combined with incor-
rect circadian timing of cell cycle events is likely to create a
highly mutagenic environment for cells in the tumor and pro-
mote tumourigenesis even further. Genomic instability and sus-
tained proliferative signaling are cancer hallmarks.50 We
therefore identified a crucial role for the zebrafish skin clock,
which is to time the cell cycle to periods of darkness or times of
highest active DNA repair in order to confer protection from
UV in dividing cells.
What might be the cause of this decoupling between the cellu-
lar clock and the timing of mitotic events within the melanoma?
Light is typically believed to be the dominant entraining signal
for the circadian clock. However, glucocorticoid signaling has
also been shown to play a key role in entrainment, especially of
peripheral circadian pacemakers.51 Moreover, the presence of
glucocorticoid signaling/cortisol has been shown to be important
for the control of rhythmic cell cycle events in healthy tissues dur-
ing zebrafish embryo development.52 In the case of the strong rx3
zebrafish mutants, which possess fewer corticotropes within the
anterior pituitary and reduced levels of cortisol, the molecular cir-
cadian clock appears to be normal, but there is a strong reduction
in the amplitude of the circadian rhythm in S-phase, as measured
by BrdU incorporation into the skin. Tonic treatment of strong
rx3 mutant larvae with the glucocorticoid receptor agonist, dexa-
methasone, can largely rescue this cell cycle rhythm, re-establish-
ing the coupling between clock and cell cycle. These results have
some clear similarities with the data we have obtained in mela-
noma. Though the clock in the tumor is somewhat more dis-
rupted, especially in terms of the light input pathway, it is still
able to show clear daily molecular oscillations, yet it is the cou-
pling to control mitotic rhythms that is clearly lost. This raises
the interesting possibility that there maybe a disruption in gluco-
corticoid signaling in the context of the melanoma tumor. This,
of course, could occur at many levels from disruption of gluco-
corticoid receptors in the tumor, through to perturbation of
Figure 4. Disruption in S-phase gene expression in melanoma tumor. (A) qPCR analysis of S-phase regulating genes p21, cdk2, and PCNA in skin and
tumor. Relative expression to the reference gene represents the mean § SEM of a minimum of 5 samples per time point. (B) Cosinor analysis from qPCR
values presented in (A). Data represent the mesor and amplitude in relative expression, the acrophase in circadian time and the signiﬁcance of rhythmic-
ity (*P< 0.05; ***P < 0.001) for skin and tumor in LD and DD regimes.
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cortisol levels in an unhealthy animal. Clearly, future studies will
need to explore the possible role played by glucocorticoid signal-
ing in coupling clock and cell cycle, especially during the process
of tumourigenesis. Zebrafish melanoma certainly offers a unique
model in which to study the intricate link between the circadian
clock, signaling pathways and the cell cycle.
Revealing how clock-cell cycle interactions function in a
cancer environment is an important issue, not only to under-
stand the circadian biology of cancer, but also to provide
insights on how to improve cancer treatment through chrono-
therapy. Chronotherapeutic regimes, delivering drugs at spe-
cific times of the day for optimal drug action and reduced
toxic side effects, have already shown promising results in met-
astatic prostate cancer patients in a timed regime compared to
conventional treatment.21 The circadian profile of cell cycle
genes generated in this study clearly points to an asynchrony
in melanoma tumors compared to healthy skin cells. In such a
scenario, the potential exists, therefore, to apply drugs to kill
cancer cells at a time where there will be minimal impact on
healthy tissue. Zebrafish have already been described as an
excellent model for pharmacological studies and future experi-
ments will assess the efficacy of key melanoma drugs within a
chronochemotherapeutic regime.
Materials and Methods
Animal husbandry
Tg(mitfa:V12Ras); mitfa¡/¡ animals were obtained from Dr.
Adam Hurlstone (University of Manchester) and were raised and
maintained in the zebrafish animal facility of University College
London, as previously described.53 All animals were held in a
Home Office approved animal facility and in accordance with
Home Office regulations regarding animal maintenance and
care. Animal handling has been approved by a UCL ethics com-
mittee and meets all of the requirements of the Animal Welfare
Act of 2006. Individual experiments were performed under ani-
mal license number PIL 40/3292. Animals were sacrificed in
accordance with Schedule 1 of the Animal Welfare Act of 2006,
to ensure minimal suffering. Adult fish were kept in light cabinets
and exposed to a lighting regime of 14L/10D unless stated
otherwise.
Generation of transgenic melanoma fish
The miniCoopR GFP vector was a gift from Adam Hurlstone
(University of Manchester).36 75pg of miniCoopR-GFP vector
and 75pg of tol2 transposase mRNA were microinjected into
one-cell stage embryos generated from a (mitfa:RasV12); mitfa¡/¡
£
mitfa¡/¡ zebrafish cross. Transgenic animals recapitulated a
melanoma tumor phenotype observed in the Tg(mitfa:RasV12),35
but with an earlier onset of 4 weeks of age and with far greater
penetrance as all fish developed tumors. Animals developing
either melanoma tumors or normal pigmentation were used for
tumor and skin sample collection, respectively. It should be
noted that the tumor bearing fish are culled before the size of the
tumor affect their feeding and swimming, so the presence of the
tumor does not affect fish survival.
Quantitative PCR (qPCR)
Adult skin and tumor samples were harvested at the indicated
zeitgeber or circadian time (ZT or CT, where ZT0 equals lights
on). RNA extraction, cDNA synthesis and qPCR experiments were
carried out as previously described.8 DCT was calculated using
ribosomal 18S as a reference gene. Relative expression levels were
plotted after determining DDCt by normalizing to a single sample
with a highDCT value. Primer sequences are listed inTable S7.
Bioluminescence assays
Skin and tumor samples from V12RasC; GFPC and GFPC
injected animals in a per3-luciferase background were dissected
and placed in medium containing 0.5mM of luciferin (Promega)
in a 96-well plate. Samples were maintained at 28C on a light-
dark (LD) cycle (12L:12D) and transferred into either constant
darkness (DD) or a reverse light/dark cycle. Bioluminescence was
monitored on a Packard TopCount NXTscintillation counter.
The luminescent rhythm parameters (phase and amplitude) were
calculated after detrending by subtracting a 24-h moving average
from the raw data.
Phospho-Histone H3 immunohistochemistry
Whole zebrafish were fixed at specified time points on a LD
cycle33 and sectioned as previously described49 with the following
changes. Animals were fixed in 4% PFA in 0.1 phosphate buffer
at 4C for 5 days, then transferred to a 0.25 M EDTA solution
for 3 days at room temperature. EDTA was rinsed off with water
before immersing the samples in 30% sucrose solution for an
additional 2 days. Tumor-bearing and healthy fish were cryosec-
tioned at 10mm and stained, as previously described.49 Images
were collected using a Zeiss AxioScan Z1 slide scanner. Quantifi-
cation of pH3-positive cells was calculated relative to the total
number of cell nuclei in skin layers, stained with DAPI and
within the GFP-labeled tumor area.
Statistical analysis
The data in this study are presented as the mean § SEM (n 
3). Statistical significance was determined by an unpaired 2-tailed
Student t-test or analysis of variance (ANOVA), followed by
Newman–Keuls multiple comparison post-test in GraphPad
Prism.
Light pulse experiments
Fish were kept on a LD cycle for 7 days before being trans-
ferred to DD. At CT16 on the first DD night, animals were
exposed to a 3 h light pulse using LED lights with an average
intensity of 65 mW/cm2.
Rhythm analysis
Rhythm analyses were performed by the Cosinor method
(Nelson et al. 1979), using the El Temps software developed by
Prof. A. Dıez Noguera. Rhythms are considered significant when
www.tandfonline.com 1239Cell Cycle
P < 0.05. *P < 0.05; **P < 0.01; ***P < 0.001 and non-signifi-
cant rhythms when P < 0.1.
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